BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Harvard Business School
Baxter
Boehringer Ingelheim
Healthtrust
US Army
McKesson
Medtronic
Johnson and Johnson
Daiichi Sankyo

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050767

« Back to Dashboard

NDA 050767 describes CLEOCIN, which is a drug marketed by Pharmacia And Upjohn and is included in fourteen NDAs. It is available from three suppliers. There is one patent protecting this drug. Additional details are available on the CLEOCIN profile page.

The generic ingredient in CLEOCIN is clindamycin palmitate hydrochloride. There are fifty-three drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.
Summary for 050767
Tradename:CLEOCIN
Applicant:Pharmacia And Upjohn
Ingredient:clindamycin phosphate
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 050767
Ingredient-typeLincosamides
Physiological EffectDecreased Sebaceous Gland Activity
Suppliers and Packaging for NDA: 050767
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLEOCIN clindamycin phosphate SUPPOSITORY;VAGINAL 050767 NDA Pharmacia and Upjohn Company LLC 0009-7667 0009-7667-01 1 BLISTER PACK in 1 CARTON (0009-7667-01) > 3 SUPPOSITORY in 1 BLISTER PACK
CLEOCIN clindamycin phosphate SUPPOSITORY;VAGINAL 050767 NDA U.S. Pharmaceuticals 63539-011 63539-011-01 1 BLISTER PACK in 1 CARTON (63539-011-01) > 3 SUPPOSITORY in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUPPOSITORY;VAGINALStrength100MG
Approval Date:Aug 13, 1999TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Jul 20, 2020Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Daiichi Sankyo
Express Scripts
Moodys
US Army
QuintilesIMS
Novartis
Cerilliant
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot